IDH2 and central nervous system cancer: For differentiating IDH-mutant from IDH-wildtype gliomas, volcano plot analysis identified 18 metabolite features with high confidence (P < 0.05, fold change > 1.5 or < 2/3) (Figure 4C, 4G).